OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc. (OKUR) Revenue
Annual & quarterly revenue history · segment & region breakdown
OKUR · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsOnKure Therapeutics, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income OnKure Therapeutics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
OnKure Therapeutics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from OnKure Therapeutics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
OKUR revenue · 4 questionsOKUR's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · OnKure Therapeutics, Inc. SEC filings · GAAP · OnKure Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026